Erectile dysfunction

Known as: Dysfunction, Erectile, dysfunction erectile, erectile dysfunctions 
A disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Erectile dysfunction is a common clinical entity that affects mainly men older than 40 years. In addition to the classical causes… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A BSTRACT Background Sildenafil is a potent inhibitor of cyclic guanosine monophosphate in the corpus cavernosum and therefore… (More)
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE We estimated the incidence of erectile dysfunction in men 40 to 69 years old at study entry during an average 8.8-year… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Erectile dysfunction (ED), a wide spread and troublesome condition among middle-aged men, is partly vascular in origin… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
An abridged five-item version of the 15-item International Index of Erectile Function (IIEF) was developed (IIEF-5) to diagnose… (More)
  • table 1
  • table 2
  • figure 1
  • table 4
  • table 3
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVES To project the likely worldwide increase in the prevalence of erectile dysfunction (ED) over the next 25 years, and to… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVES To evaluate the erectile function (EF) domain of the International Index of Erectile Function (IIEF) as a diagnostic… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Sildenafil is a potent inhibitor of cyclic guanosine monophosphate hydrolysis [corrected] in the corpus cavernosum and… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Sildenafil (Viagra, UK-92,480) is a novel oral agent under development for the treatment of penile erectile dysfunction. Erection… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVES To determine the efficacy and safety of sildenafil, a novel orally active inhibitor of the type-V cyclic guanosine… (More)
Is this relevant?